Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: Final results from a pivotal study Letter uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Drug Resistance, Neoplasm
  • Leukemia, Lymphocytic, Chronic, B-Cell

publication date

  • January 2015

Research

keywords

  • Letter

Identity

Digital Object Identifier (DOI)

  • 10.3324/haematol.2014.121459

PubMed ID

  • 25769539

Additional Document Info

start page

  • e311

end page

  • 4

volume

  • 100

number

  • 8